Business, energy, technology, markets and global industry news from Business News Today

Medical Devices & Diagnostics

PharmaDeviceNews Medical Devices & Diagnostics
Representative image of an orthopedic surgical team reviewing ACL reconstruction anatomy and knee imaging, illustrating CoreTissue BioEngineering’s CT-ACL001 tissue-regenerative ligament trial and its potential role in advancing anterior cruciate ligament repair.
Medical Devices & Diagnostics

CoreTissue BioEngineering pushes ACL device strategy beyond early safety testing

ACL surgery needs better graft choices. CoreTissue BioEngineering’s CT-ACL001 now faces the harder randomized test.

Read More
Mevion’s S250-FIT arrives in Europe with a sharper pitch for proton therapy access
Medical Devices & Diagnostics

Can Mevion’s S250-FIT make proton therapy practical for more cancer centers?

Proton therapy has long had an infrastructure problem. Mevion’s S250-FIT asks whether existing LINAC vaults can change that.

Read More
Representative image: A wearable health platform displays biometric trends, AI coaching insights, and a virtual clinician consultation, reflecting WHOOP’s push into connected digital health, on-demand clinical support, and personalized wellness intelligence.
Medical Devices & Diagnostics

Is WHOOP quietly turning its fitness band into a front door for healthcare?

Wearables collect more health data than ever. WHOOP is betting clinicians and AI can turn that flood into real decisions.

Read More
Representative image of a precision retina surgery procedure using advanced vitrectomy technology, reflecting Bausch + Lomb’s Bi-Blade+ launch in Europe and the growing focus on surgical control, fluidics stability and vitreoretinal workflow efficiency.
Medical Devices & Diagnostics

Can Bi-Blade+ strengthen Bausch + Lomb’s position in European retina surgery?

A faster cutter is only part of the story. Bausch + Lomb’s Bi-Blade+ launch tests whether surgical platform upgrades can drive loyalty.

Read More
Representative image of an advanced neurovascular stroke procedure, illustrating how Rapid Medical’s TIGERTRIEVER 13 DISTALS trial data could support wider interest in small-vessel thrombectomy for distal and medium vessel occlusion stroke.
Medical Devices & Diagnostics

Why Rapid Medical’s DISTALS data could reshape treatment expectations in smaller stroke vessels

Distal stroke has long lacked device options. Rapid Medical’s TIGERTRIEVER 13 data now tests whether small-vessel thrombectomy can scale.

Read More
Representative image: A dry powder inhaler prototype is shown in a pharmaceutical research setting, reflecting Phillips Medisize’s focus on connected inhaler innovation, device-formulation alignment, and patient-centric respiratory drug delivery at RDD 2026.
Medical Devices & Diagnostics

Phillips Medisize targets formulation-device risk as inhaled therapies grow more complex

Inhalers are getting smarter, but complexity can backfire. Phillips Medisize is betting DPI success starts with patient-centric design.

Read More
Representative image of an advanced endoscopy suite, illustrating how Fujifilm’s ELUXEO 8000 imaging system and EG-840TP gastroscope highlight the growing role of precision visualization in minimally invasive gastrointestinal procedures.
Medical Devices & Diagnostics

Fujifilm’s ELUXEO 8000 and EG-840TP pairing raises the bar in interventional endoscopy

Advanced GI procedures need better visualization. Fujifilm’s ELUXEO 8000 win shows why imaging may decide adoption.

Read More
Representative image of a child receiving a needle-free polio vaccine during a community immunisation campaign, highlighting PharmaJet’s Tropis system and Nigeria’s push to close vaccine coverage gaps.
Medical Devices & Diagnostics

Can PharmaJet’s needle-free Tropis system help Nigeria close its polio gap?

Nigeria has polio tools, but coverage gaps remain. PharmaJet’s Tropis campaign tests whether needle-free delivery can close the last mile.

Read More
Medical Devices & Diagnostics

Why Sensus Healthcare’s SkinCure resolution matters for superficial radiotherapy growth

Sensus settled the dispute, but the harder test is SRT adoption. Can reimbursement momentum turn into durable medtech growth?

Read More
Representative image of a clinician reviewing lung CT scans and noninvasive sputum-based testing, as bioAffinity Technologies reports rising CyPath Lung adoption and growing interest in early lung cancer diagnostic tools.
Medical Devices & Diagnostics

Why bioAffinity’s CyPath Lung growth still leaves investors facing a hard cash question

CyPath Lung is gaining clinical traction. The harder test is whether bioAffinity can scale adoption before cash pressure tightens.

Read More